ExecuPharm
Last update: October 23, 2020
Pharmaceuticals
United States (USA)
Its 5 main executivesRecent executive movements at Parexel International
Clare Grace has joined the company as Chief Patient Officer (news posted on January 5 2021).
Create an alert
to follow the executive moves at ExecuPharm.
Most searched biographies at ExecuPharm
- Stowe Milhous, General Manager
- Lauri Sirabella, Senior Vice President, Clinical Operations
- Dave Granese, Vice President, Business Development
Click on an executive to view his biography >
Latest M&A news in Pharmaceuticals.
Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).
Other contacts in the Pharmaceuticals industry
Latest news about ExecuPharm
ExecuPharm on Wikipedia, Google News & Yahoo Finance
ExecuPharm on LinkedIn, Twitter & YouTube
ExecuPharm has 2,034 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland). ExecuPharm is owned by Parexel International.
Contact by email its executives including Stowe Milhous 
